https://ml351inhibitor.com/the....-actual-long-term-re
Background： Paeonol (Pae)， the main active compound associated with reason behind Paeonia albiflora, is effective in dealing with atherosclerosis (AS). Endothelial dysfunction is through the pathological progression of AS. It is anticipated that inhibition of Endothelial-to-mesenchymal change (EndMT) is going to be a vital target for AS therapy. Objective： In this study, we investigated the molecular mechanism of the regulatory effect of Pae on EndMT
Like
Comment
Share
